Prognostic significance of altered miRNA expression in whole blood of OSCC patients

Ries,Jutta; Baran,Christoph; Wehrhan,Falk; Weber,Manuel; Neukam,Friedrich W.; Krautheim-Zenk,Andrea; Nkenke,Emeka

doi:10.3892/or.2017.5639

Prognostic significance of altered miRNA expression in whole blood of OSCC patients

Authors:
- Jutta Ries
- Christoph Baran
- Falk Wehrhan
- Manuel Weber
- Friedrich W. Neukam
- Andrea Krautheim-Zenk
- Emeka Nkenke
View Affiliations

Affiliations: Department of Oral and Maxillofacial Surgery, Erlangen University Hospital, D-91054 Erlangen, Germany, Department of Oral and Maxillofacial Surgery, Medical University Vienna, A-1090 Vienna, Austria
Published online on: May 11, 2017 https://doi.org/10.3892/or.2017.5639
Pages: 3467-3474

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Currently, there is a lack of blood markers for the detection of recurrent oral squamous cell carcinoma (OSCC). The present study aimed to investigate whether the aberrant expression of single microRNAs (miRNAs) in whole blood of patients could serve as a biomarker for persistent or recurrent OSCC. Whole blood of 2 groups of formerly treated OSCC patients was investigated by RT-qPCR for their circulating miRNA profiles. The R-OC group included patients with recurrence of OSCC (n=21) and the NR-OC group included patients without recurrence (n=21). Fold-changes and significance of the differences in miRNA expression levels between the groups were determined. A cut-off point (COP) for the discrimination between the R-OC and NR-OC groups was calculated and the significance between over/under expression of the miRNAs and the recurrence of malignancy was determined. Significant differences in the miRNA expression in whole blood of the R-OC and NR-OC groups were found. The levels of miR-3651 and miR-494 were significantly increased and the level of miR-186 was significantly decreased in whole blood of the R-OC patients (pmiR-3651=0.001, pmiR-494=0.003 and pmiR-186=0.001). By the determination of the COP, increased or decreased expression of the markers was significantly correlated to the recurrence of the disease. Altered expression of miR-494, miR-3651 and miR-186 appears to be associated with the recurrence of OSCC. The present study may form the basis for establishing a blood test as a minimally invasive method for the detection of the recurrence of OSCC.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
2	Yanamoto S, Yamada S, Takahashi H, Yoshitomi I, Kawasaki G, Ikeda H, Minamizato T, Shiraishi T, Fujita S, Ikeda T, et al: Clinicopathological risk factors for local recurrence in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 41:1195–1200. 2012. View Article : Google Scholar : PubMed/NCBI
3	Wang B, Zhang S, Yue K and Wang XD: The recurrence and survival of oral squamous cell carcinoma: A report of 275 cases. Chin J Cancer. 32:614–618. 2013. View Article : Google Scholar : PubMed/NCBI
4	Agra IM, Carvalho AL, Pinto CA, Martins EP, Filho JG, Soares FA and Kowalski LP: Biological markers and prognosis in recurrent oral cancer after salvage surgery. Arch Otolaryngol Head Neck Surg. 134:743–749. 2008. View Article : Google Scholar : PubMed/NCBI
5	Kalavrezos N and Bhandari R: Current trends and future perspectives in the surgical management of oral cancer. Oral Oncol. 46:429–432. 2010. View Article : Google Scholar : PubMed/NCBI
6	Ord RA, Kolokythas A and Reynolds MA: Surgical salvage for local and regional recurrence in oral cancer. J Oral Maxillofac Surg. 64:1409–1414. 2006. View Article : Google Scholar : PubMed/NCBI
7	Schwartz GJ, Mehta RH, Wenig BL, Shaligram C and Portugal LG: Salvage treatment for recurrent squamous cell carcinoma of the oral cavity. Head Neck. 22:34–41. 2000. View Article : Google Scholar : PubMed/NCBI
8	Søland TM and Brusevold IJ: Prognostic molecular markers in cancer - quo vadis? Histopathology. 63:297–308. 2013. View Article : Google Scholar : PubMed/NCBI
9	Huang TY, Hsu LP, Wen YH, Huang TT, Chou YF, Lee CF, Yang MC, Chang YK and Chen PR: Predictors of locoregional recurrence in early stage oral cavity cancer with free surgical margins. Oral Oncol. 46:49–55. 2010. View Article : Google Scholar : PubMed/NCBI
10	Chauhan SS, Kaur J, Kumar M, Matta A, Srivastava G, Alyass A, Assi J, Leong I, MacMillan C, Witterick I, et al: Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer. Oncogenesis. 4:e1472015. View Article : Google Scholar : PubMed/NCBI
11	Komatsu S, Ichikawa D, Hirajima S, Kawaguchi T, Miyamae M, Okajima W, Ohashi T, Arita T, Konishi H, Shiozaki A, et al: Plasma microRNA profiles: Identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma. Br J Cancer. 111:1614–1624. 2014. View Article : Google Scholar : PubMed/NCBI
12	Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20. 2005. View Article : Google Scholar : PubMed/NCBI
13	Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
14	Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al: MicroRNA expression profiles classify human cancers. Nature. 435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
15	Cortez MA and Calin GA: MicroRNA identification in plasma and serum: A new tool to diagnose and monitor diseases. Expert Opin Biol Ther. 9:703–711. 2009. View Article : Google Scholar : PubMed/NCBI
16	Momen-Heravi F, Trachtenberg AJ, Kuo WP and Cheng YS: Genomewide study of salivary microRNAs for detection of oral cancer. J Dent Res. 93 Suppl 7:86S–93S. 2014. View Article : Google Scholar : PubMed/NCBI
17	Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 105:pp. 10513–10518. 2008; View Article : Google Scholar : PubMed/NCBI
18	Witwer KW: Circulating microRNA biomarker studies: Pitfalls and potential solutions. Clin Chem. 61:56–63. 2015. View Article : Google Scholar : PubMed/NCBI
19	Cappelletti V, Appierto V, Tiberio P, Fina E, Callari M and Daidone MG: Circulating biomarkers for prediction of treatment response. J Natl Cancer Inst Monogr. 2015:60–63. 2015. View Article : Google Scholar : PubMed/NCBI
20	Tiberio P, Callari M, Angeloni V, Daidone MG and Appierto V: Challenges in using circulating miRNAs as cancer biomarkers. BioMed Res Int. 2015:7314792015. View Article : Google Scholar : PubMed/NCBI
21	Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
22	Allegra A, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D and Musolino C: Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). Int J Oncol. 41:1897–1912. 2012.PubMed/NCBI
23	Schwarzenbach H, Nishida N, Calin GA and Pantel K: Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol. 11:145–156. 2014. View Article : Google Scholar : PubMed/NCBI
24	Iorio MV and Croce CM: MicroRNA dysregulation in cancer: Diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
25	Gomes CC, de Sousa SF and Gomez RS: MicroRNAs: Small molecules with a potentially role in oral squamous cell carcinoma. Curr Pharm Des. 19:1285–1291. 2013. View Article : Google Scholar : PubMed/NCBI
26	Wu BH, Xiong XP, Jia J and Zhang WF: MicroRNAs: New actors in the oral cancer scene. Oral Oncol. 47:314–319. 2011. View Article : Google Scholar : PubMed/NCBI
27	Soga D, Yoshiba S, Shiogama S, Miyazaki H, Kondo S and Shintani S: microRNA expression profiles in oral squamous cell carcinoma. Oncol Rep. 30:579–583. 2013.PubMed/NCBI
28	Zahran F, Ghalwash D, Shaker O, Al-Johani K and Scully C: Salivary microRNAs in oral cancer. Oral Dis. 21:739–747. 2015. View Article : Google Scholar : PubMed/NCBI
29	Hanash SM, Baik CS and Kallioniemi O: Emerging molecular biomarkers - blood-based strategies to detect and monitor cancer. Nat Rev Clin Oncol. 8:142–150. 2011. View Article : Google Scholar : PubMed/NCBI
30	Wu JY, Yi C, Chung HR, Wang DJ, Chang WC, Lee SY, Lin CT, Yang YC and Yang WC: Potential biomarkers in saliva for oral squamous cell carcinoma. Oral Oncol. 46:226–231. 2010. View Article : Google Scholar : PubMed/NCBI
31	Ries J, Vairaktaris E, Agaimy A, Kintopp R, Baran C, Neukam FW and Nkenke E: miR-186, miR-3651 and miR-494: Potential biomarkers for oral squamous cell carcinoma extracted from whole blood. Oncol Rep. 31:1429–1436. 2014.PubMed/NCBI
32	Ries J, Vairaktaris E, Kintopp R, Baran C, Neukam FW and Nkenke E: Alterations in miRNA expression patterns in whole blood of OSCC patients. In Vivo. 28:851–861. 2014.PubMed/NCBI
33	Masood Y, Kqueen CY and Rajadurai P: Role of miRNA in head and neck squamous cell carcinoma. Expert Rev Anticancer Ther. 15:183–197. 2015. View Article : Google Scholar : PubMed/NCBI
34	Ganci F, Sacconi A, Manciocco V, Sperduti I, Battaglia P, Covello R, Muti P, Strano S, Spriano G, Fontemaggi G, et al: MicroRNA expression as predictor of local recurrence risk in oral squamous cell carcinoma. Head Neck. 38 Suppl 1:E189–E197. 2016. View Article : Google Scholar : PubMed/NCBI
35	Xiao W, Bao ZX, Zhang CY, Zhang XY, Shi LJ, Zhou ZT and Jiang WW: Upregulation of miR-31* is negatively associated with recurrent/newly formed oral leukoplakia. PLoS One. 7:e386482012. View Article : Google Scholar : PubMed/NCBI
36	Gorenchtein M, Poh CF, Saini R and Garnis C: MicroRNAs in an oral cancer context - from basic biology to clinical utility. J Dent Res. 91:440–446. 2012. View Article : Google Scholar : PubMed/NCBI
37	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
38	Kowalski LP and Sanabria A: Elective neck dissection in oral carcinoma: A critical review of the evidence. Acta Otorhinolaryngol Ital. 27:113–117. 2007.PubMed/NCBI
39	Grimm M, Kraut W, Hoefert S, Krimmel M, Biegner T, Teriete P, Cetindis M, Polligkeit J, Kluba S, Munz A, et al: Evaluation of a biomarker based blood test for monitoring surgical resection of oral squamous cell carcinomas. Clin Oral Investig. 20:329–338. 2016. View Article : Google Scholar : PubMed/NCBI
40	Gomes CC and Gomez RS: MicroRNA and oral cancer: Future perspectives. Oral Oncol. 44:910–914. 2008. View Article : Google Scholar : PubMed/NCBI
41	Yoshizawa JM and Wong DT: Salivary microRNAs and oral cancer detection. Methods Mol Biol. 936:313–324. 2013. View Article : Google Scholar : PubMed/NCBI
42	Zen K and Zhang CY: Circulating microRNAs: A novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev. 32:326–348. 2012. View Article : Google Scholar : PubMed/NCBI
43	Summerer I, Niyazi M, Unger K, Pitea A, Zangen V, Hess J, Atkinson MJ, Belka C, Moertl S and Zitzelsberger H: Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients. Radiat Oncol. 8:2962013. View Article : Google Scholar : PubMed/NCBI
44	Gombos K, Horváth R, Szele E, Juhász K, Gocze K, Somlai K, Pajkos G, Ember I and Olasz L: miRNA expression profiles of oral squamous cell carcinomas. Anticancer Res. 33:1511–1517. 2013.PubMed/NCBI
45	Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Morimura R, Nagata H, Kosuga T, Iitaka D, Konishi H, Shiozaki A, et al: Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer. 105:104–111. 2011. View Article : Google Scholar : PubMed/NCBI
46	Liu CJ, Kao SY, Tu HF, Tsai MM, Chang KW and Lin SC: Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis. 16:360–364. 2010. View Article : Google Scholar : PubMed/NCBI
47	Lin SC, Liu CJ, Lin JA, Chiang WF, Hung PS and Chang KW: miR-24 up-regulation in oral carcinoma: Positive association from clinical and in vitro analysis. Oral Oncol. 46:204–208. 2010. View Article : Google Scholar : PubMed/NCBI
48	Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP and Wei WI: Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res. 14:2588–2592. 2008. View Article : Google Scholar : PubMed/NCBI
49	Liu CJ, Lin SC, Yang CC, Cheng HW and Chang KW: Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. Head Neck. 34:219–224. 2012. View Article : Google Scholar : PubMed/NCBI
50	Grimm M, Schmitt S, Teriete P, Biegner T, Stenzl A, Hennenlotter J, Muhs HJ, Munz A, Nadtotschi T, König K, et al: A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells. BMC Cancer. 13:5692013. View Article : Google Scholar : PubMed/NCBI
51	Friedman EB, Shang S, de Miera EV, Fog JU, Teilum MW, Ma MW, Berman RS, Shapiro RL, Pavlick AC, Hernando E, et al: Serum microRNAs as biomarkers for recurrence in melanoma. J Transl Med. 10:1552012. View Article : Google Scholar : PubMed/NCBI
52	Schwarzenbach H, Hoon DS and Pantel K: Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 11:426–437. 2011. View Article : Google Scholar : PubMed/NCBI
53	Maclellan SA, Lawson J, Baik J, Guillaud M, Poh CF and Garnis C: Differential expression of miRNAs in the serum of patients with high-risk oral lesions. Cancer Med. 1:268–274. 2012. View Article : Google Scholar : PubMed/NCBI